BRIEF-Biotec Pharmacon issued new patent for cancer adjuvant therapy

Wed Aug 6, 2014 9:13am EDT

Related Topics

Aug 6 (Reuters) - Biotec Pharmacon ASA : * Issued new patent for cancer adjuvant therapy * Says the patent US 8,791,252 is for a method of treating a variety of different cancers by administrating a combination of a (1,3) beta-glucan and a complement-activating antibody * Source text for Eikon * Further company coverage

FILED UNDER: